- Country: United Kingdom
- Summary: Medicinal Product Trial -Metformin
- GBT Ref No: 124294783
- Deadline: 05 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The trust was successful in obtaining a grant from NIHR for a clinical trial to look at the use of metformin in people newly diagnosed with psychosis. The clinical trial (including the recruitment phase) is estimated to take place between June 2026 to November 2028. As part of that grant we need to source a supplier that has the capability to purchase or manufacture Metformin and an identical placebo for a clinical trial, to package and label both to our requirements and distribute to Trusts across the UK in a predetermined schedule.
CPV classifications: 73300000 - Design and execution of research and development - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicinal Product Trial -Metformin - Uk Tender
The PENNINE CARE NHS FOUNDATION TRUST, a Government sector organization in United Kingdom, has announced a new tender for Medicinal Product Trial -Metformin. This tender is published on UkTender under GBT Ref No: 124294783 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
